MedWatch

Analyst on US Coloplast contract: Important contract – volumes will probably increase

It's incredibly important for Coloplast that the medtech company has landed a deal to sell ostomy products by way of the largest group purchasing organization in the US, Vizient, according to senior equity analyst. He expects the new contract will lead to increased volumes in the long term.

Photo: Sydbank/PR

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list Hear.com, which handles online sales.

Further reading

Related articles

Latest news

See all jobs